A Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss

October 2022 | Volume 21 | Issue 10 | 1140 | Copyright © October 2022


Published online September 26, 2022

Dillon Nussbaum BS, Emily Murphy MD, Kamaria Nelson MD, Adrianna Gonzalez-Lopez MD, Azam Qureshi MD, Julia Schwartz MD FAAD, Adam Friedman MD FAAD

George Washington University Department of Dermatology, George Washington University School of Medicine and Health Sciences, Washington, DC

DISCLOSURES

The authors declare no conflict of interest, funding, or disclosures to report.

REFERENCES

1. Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):136-141.e5.
2. Varothai S, Bergfeld WF. Androgenetic alopecia: an evidence-based treatment update. Am J Clin Dermatol. 2014;15(3):217-230.
3. Messenger AG, McKillop J, Farrant P, McDonagh AJ, Sladden M. British Association of Dermatologists' guidelines for the management of alopecia areata 2012. Br J Dermatol. 2012;166(5):916-926.
4. Herskovitz I, Miteva M. Central centrifugal cicatricial alopecia: challenges and solutions. Clin Cosmet Investig Dermatol. 2016;9:175-181.
5. Olsen EA, Messenger AG, Shapiro J, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol. 2005;52(2):301-311.
6. DiMarco G, McMichael A. Hair Loss Myths. J Drugs Dermatol. 2017;16(7):690-694.

AUTHOR CORRESPONDENCE

Adam Friedman MD FAAD ajfriedman@mfa.gwu.edu